Product Images Tranexamic Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Tranexamic Acid NDC 63629-8838 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - lbl636298838
This is a product description of Tranexamic Acid Tablet, USP by BRP Pharmaceuticals, intended for prescription only. The tablets contain Tranexamic Acid, each containing 650 mg. The recommended dosage is taking two 650 mg tablets, three times per day during menstruation, with a maximum of 6 tablets per day. Each package has 30 tablets with NDC 63629-8838-1. Store in a controlled room temperature, in a tightly closed and light-resistant container.*
Structural Formula for Tranexamic Acid - tranexamic acid tablets a202093 1
Figure 1 - The efficacy of Tranexamic acid tablets 3900 mg/day over 3 menstrual cycles and over 6 menstrual cycles was demonstrated versus placebo in the double-blind, placebo-controlled efficacy studies. - tranexamic acid tablets a202093 2
This text appears to be a table displaying the Mean Menstrual Blood Loss (in mL) for different treatments and cycles. The treatments listed are Tranexamic Acd Talls 3300 mgiay cycestudy, Placebo el study, Tranexamic Ack Tabiets 3900 mojdsy el study, and Placebo Gycl study. The cycles listed are Baseline, First Cycle, Second Cycle, Third Cycle, Fourth Cycle, Fifth Cycle, and Sixth Cycle. The table is likely part of a scientific or medical study evaluating the effectiveness of different treatments for menstrual bleeding.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.